Aldesleukin trials for Metastatic Cancer

All Aldesleukin trials · All Metastatic Cancer trials

Phase breakdown

Recruiting trials studying Aldesleukin for Metastatic Cancer

• Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
  NCT05296564 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
  NCT05686226 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
  NCT05267626 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations

Common questions

How many trials study Aldesleukin for Metastatic Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.